Ward off effects of aging with fresh fruits, ‘neurobics,’ activities – Article by Dr. Greg Jicha.
The University of Kentucky College of Public Health will hold its 28th Annual Summer Series on Aging, one of the premier aging conferences in the nation. The conference will take place June 13-15 at the Griffin Gate Marriott Resort and Spa in Lexington.
A new, exciting piece of equipment will soon be up and running in the University of Kentucky Sanders-Brown Center on Aging. The Aperio ScanScope instrument, purchased with a $283,000 grant from the National Institutes of Health, will enable Sanders-Brown researchers to study brain tissues in a new way, and to create a "digital brain bank" of data on donated brain tissue.
Scout Diagnostics, a company targeting early diagnosis of Alzheimer’s disease, recently received matching funds of $435,600 to support developing a laboratory test to detect and confirm Alzheimer’s disease in its earliest stages. Scout was formed in 2006 by University of Kentucky chemistry professors and Sanders-Brown Center on Aging researchers Mark Lovell and Bert Lynn, along with CEO John Beran.
In a seven-minute video, available for viewing on the University of Kentucky's YouTube channel, Gregory A. Jicha, M.D., Ph.D. narrates the spinal fluid donation procedure as it is performed on him. Other researchers from the Sanders-Brown Center on Aging join Jicha in providing facts about Alzheimer's disease and the importance of spinal fluid in Alzheimer's research.
Dr. Peter Nelson of the University of Kentucky Sanders-Brown is the lead author on a paper published in the journal BRAIN; the paper deals with the little-understood but serious condition hippocampal sclerosis (HS-AGING). He is also the recipient of a newly approved grant from the National Institutes of Health (NIH) to conduct a study of HS-AGING genetics.
Linda J. Van Eldik, director of the University of Kentucky Sanders-Brown Center on Aging, has been awarded a $750,000 grant to further her research into a possible treatment for Alzheimer's Disease. The grant is from the Edward N. And Della L. Thome Memorial Foundation, and is one of only eight Awards in Alzheimer's Disease Drug Discovery Research to be given in the U.S. in 2010.